- Home
- SND vs PALI Comparison
SND vs PALI Comparison
Compare SND & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SND | PALI |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | 318 | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.5M | 240.2M |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SND | PALI |
|---|---|---|
| Price | $4.10 | $1.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 441.5K | ★ 3.0M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $330,153,000.00 | $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $136.00 | ★ N/A |
| Revenue Growth | 6.03 | ★ 1500.39 |
| 52 Week Low | $1.76 | $0.55 |
| 52 Week High | $5.59 | $2.64 |
Technical Indicators
Market Signals| Indicator | SND | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 44.54 |
| Support Level | $3.51 | $1.57 |
| Resistance Level | $4.39 | $1.93 |
| Average True Range (ATR) | 0.34 | 0.11 |
| MACD | -0.18 | -0.00 |
| Stochastic Oscillator | 9.10 | 21.62 |
Price Performance
Historical ComparisonAbout SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.